Drug profile · INN
sitagliptin hydrochloride monohydrate
SITAGLIPTIN / METFORMIN HYDROCHLORIDE MYLAN
sitagliptin hydrochloride monohydrate (SITAGLIPTIN / METFORMIN HYDROCHLORIDE MYLAN) is a dipeptidyl peptidase iv inhibitor.
EMA: approved Alimentary tract and metabolism (A10) A10BD07
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sitagliptin hydrochloride monohydrate
- Class
- Alimentary tract and metabolism (A10)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
sitagliptin hydrochloride monohydrate (SITAGLIPTIN / METFORMIN HYDROCHLORIDE MYLAN) is a dipeptidyl peptidase iv inhibitor.
Key facts
INN sitagliptin hydrochloride monohydrate
Brand SITAGLIPTIN / METFORMIN HYDROCHLORIDE MYLAN
Mechanism Dipeptidyl peptidase IV inhibitor
Target Dipeptidyl peptidase 4
Therapeutic class Alimentary tract and metabolism (A10)
ATC code A10BD07
Mechanism of action
Dipeptidyl peptidase IV inhibitor
Primary target: Dipeptidyl peptidase 4
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is sitagliptin hydrochloride monohydrate?
sitagliptin hydrochloride monohydrate (SITAGLIPTIN / METFORMIN HYDROCHLORIDE MYLAN) is a dipeptidyl peptidase iv inhibitor.
What is the brand name for sitagliptin hydrochloride monohydrate?
SITAGLIPTIN / METFORMIN HYDROCHLORIDE MYLAN is a marketed brand name for sitagliptin hydrochloride monohydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.